[Seropositive people infected through intravenous drug use: a persistent vulnerability].
VESPA is a cross-sectional survey conducted among a national representative sample of HIV-infected outpatients attending French hospitals. Among the 2,932 respondents, 506 (17%) have been infected through intravenous drug use (IDU). These patients were younger and infected for a longer duration. Most of them have stopped injection, but are coinfected by HCV. We observed higher prevalences for indicators related to material vulnerability among those patients infected through IDU. These patients were also more prone to report experiences of AIDS-related discrimination, from relatives, friends, sexual partners but also from health professionals. Among patients infected through IDU, material vulnerability and experience of discrimination from health professionals were significantly associated with poor adherence to highly active antiretroviral therapies.
Observatoire régional de la santé de Provence-Alpes-Côte d'Azur, Inserm U379, Marseille. peretti@marseille.inserm.fr
Patrick
P
Peretti-Watel
Bruno
B
Spire
France
F
Lert
Yolande
Y
Obadia
D000328:Adult; D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D001291:Attitude of Health Personnel; D001294:Attitude to Health; D003430:Cross-Sectional Studies; D003625:Data Collection; D005190:Family; D005260:Female; D005602:France / Q000453:epidemiology; D006679:HIV Seropositivity / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology* / Q000635:transmission*; D006526:Hepatitis C / Q000150:complications; D020010:Heterosexuality; D006716:Homosexuality; D006801:Humans; D008297:Male; D008875:Middle Aged; D010045:Outpatients; D010349:Patient Compliance; D011287:Prejudice; D012747:Sexual Partners; D012959:Socioeconomic Factors; D015819:Substance Abuse, Intravenous / Q000150:complications*; D013997:Time Factors; D014171:Transients and Migrants
D044966:Anti-Retroviral Agents